Cardiovascular risk scores do not account for the effect of treatment: a review.
The use of risk-factor-modifying drugs-for example, statins-and disease-modifying medication-for example, platelet inhibitors-was not accounted for. In addition, none of the risk scores addressed the effect of treatment drop-ins-that is, treatment started during the study period. Ideally, a risk sco...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
2011
|
| Subjects: |